The U.S. FDA has granted accelerated approval to Eli Lilly's Retevmo (Selpercatinib) for pediatric patients two and older for ...

Wednesday, the FDA granted accelerated approval to Eli Lilly And Co’s (NYSE:LLY) selpercatinib (Retevmo) for pediatric ...

Eli Lilly said on Thursday its once-weekly insulin injection, efsitora, showed blood sugar reduction that was consistent with ...

The company said the site footprint will not expand, but the company will fill in the property with more buildings and ...

The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its ...

China gave the greenlight to Eli Lilly & Co.’s blockbuster drug tirzepatide for use in treating diabetes, a move that will ...

Eli Lilly's (NYSE: LLY) broad portfolio of drugs has helped the company's earnings climb over the years -- and in recent ...

Hims can offer the prescription weight-loss drugs because U.S. regulators have rules that allow pharmacies to make copycat ...

Eli Lilly & Co. LLY shares were on pace for a record closing high Tuesday after the drugmaker released data from a late-stage Crohn’s disease trial and struck a deal to develop new cancer ...

Eli Lilly said on Thursday that its once-weekly insulin efsitora met the main goals in two late-stage trials evaluating it in ...

The momentum the biopharma industry showed in the fourth quarter of 2023 has continued into this year. | The momentum the ...

, opens new tab said on Thursday its once-weekly insulin injection, efsitora, showed blood sugar reduction that was consistent with commonly used daily insulins across two studies in patients with ...